Q3297239 (Q3297239): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Created claim: summary (P836): Gründler GmbH develops and produces innovative medical devices for patients with acute lung failure. The company is currently working on a new, innovative therapy system. The aim is to improve the survival rate of patients with critical lung failure while reducing treatment effort, risks and treatment costs. The funding supports the construction of an administrative, production and warehouse building., translated_summary) |
||||||||||||||
| Property / summary | |||||||||||||||
Gründler GmbH develops and produces innovative medical devices for patients with acute lung failure. The company is currently working on a new, innovative therapy system. The aim is to improve the survival rate of patients with critical lung failure while reducing treatment effort, risks and treatment costs. The funding supports the construction of an administrative, production and warehouse building. (English) | |||||||||||||||
| Property / summary: Gründler GmbH develops and produces innovative medical devices for patients with acute lung failure. The company is currently working on a new, innovative therapy system. The aim is to improve the survival rate of patients with critical lung failure while reducing treatment effort, risks and treatment costs. The funding supports the construction of an administrative, production and warehouse building. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Gründler GmbH develops and produces innovative medical devices for patients with acute lung failure. The company is currently working on a new, innovative therapy system. The aim is to improve the survival rate of patients with critical lung failure while reducing treatment effort, risks and treatment costs. The funding supports the construction of an administrative, production and warehouse building. (English) / qualifier | |||||||||||||||
point in time: 24 October 2021
| |||||||||||||||
Revision as of 16:01, 24 October 2021
Project Q3297239 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3297239 in Germany |
Statements
200,000.0 Euro
0 references
400,000.0 Euro
0 references
50.0 percent
0 references
15 May 2020
0 references
14 May 2022
0 references
GuL Verwaltungs GmbH
0 references
Die Gründler GmbH entwickelt und produziert innovative Medizinprodukte für Patienten mit akutem Lungenversagen. Derzeit arbeitet das Unternehmen an einem neuen, innovativen System zur Therapie. Ziel ist es, die Überlebensrate von Patienten mit kritischem Lungenversagen zu verbessern bei gleichzeitiger Reduktion von Therapieaufwand, Risiken und Behandlungskosten. Mit der Förderung wird der Neubau eines Verwaltungs-, Produktions- und Lagergebäudes unterstützt. (German)
0 references
Gründler GmbH develops and produces innovative medical devices for patients with acute lung failure. The company is currently working on a new, innovative therapy system. The aim is to improve the survival rate of patients with critical lung failure while reducing treatment effort, risks and treatment costs. The funding supports the construction of an administrative, production and warehouse building. (English)
24 October 2021
0 references
Freudenstadt
0 references
Identifiers
DE_TEMPORARY_18
0 references